Publication | Closed Access

A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

First-line TherapyMedicineLocally AdvancedMetronomic TherapyPathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology